Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia.
Phase of Trial: Phase III
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Asparaginase (Primary)
- Indications Acute lymphoblastic leukaemia
- Focus Therapeutic Use
- Sponsors Medac
- 06 Jun 2017 Last checked against European Clinical Trials Database record.
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2011 Planned End Date changed from 1 Mar 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.